Below are the most recent publications written about "Ferritins" by people in Profiles.
-
Jafri L, Jameel Farooqui A, Moiz B, Sheikh A, Majid H, Nadeem S, Quddus R, Khan S, Khan QU, Habib Khan A. Factors associated with phosphate homeostasis in children with beta-thalassemia major: An analytical cross sectional study from Pakistan. PLoS One. 2025; 20(2):e0316566.
-
Mahmood SBZ, Majid H, Arshad A, Niazali N, Kazi K, Aslam A, Ahmed S, Jamil B, Jafri L. Interleukin-6 (IL-6) as a Predictor of Clinical Outcomes in Patients with COVID-19. Clin Lab. 2023 Jun 01; 69(6).
-
Wilson SR, Sears M, Williams E, Drapekin J, Sivakumar I, Padrino S, Desai PC, Hager W, Manwani D, Clay LJ, Field JJ, Kanter J, Cohen AJ, Saif Ur Rehman S, Lanzkron S, Little JA. Gaps in the diagnosis and management of iron overload in sickle cell disease: a 'real-world' report from the GRNDaD registry. Br J Haematol. 2021 12; 195(5):e157-e160.
-
Hiedra R, Lo KB, Elbashabsheh M, Gul F, Wright RM, Albano J, Azmaiparashvili Z, Patarroyo Aponte G. The use of IV vitamin C for patients with COVID-19: a case series. Expert Rev Anti Infect Ther. 2020 Dec; 18(12):1259-1261.
-
Ashok A, Chaudhary S, Kritikos AE, Kang MH, McDonald D, Rhee DJ, Singh N. TGF?2-Hepcidin Feed-Forward Loop in the Trabecular Meshwork Implicates Iron in Glaucomatous Pathology. Invest Ophthalmol Vis Sci. 2020 03 09; 61(3):24.
-
Sood R, Jiramongkolchai K, Streiff M, Gonzalez C, Shanbhag S, Lanzkron S, Arevalo JF, Naik R. Look into my eyes: An unusual first presentation of sickle cell disease. Am J Hematol. 2017 Sep; 92(9):968-971.
-
Wong L, Smith S, Gilstrop M, Derman R, Auerbach S, London N, Lenowitz S, Bahrain H, McClintock J, Auerbach M. Safety and efficacy of rapid (1,000 mg in 1 hr) intravenous iron dextran for treatment of maternal iron deficient anemia of pregnancy. Am J Hematol. 2016 Jun; 91(6):590-3.
-
Raman SV, Sharkey-Toppen TP, Tran T, Liu JX, McCarthy B, He X, Smart S, Gulati M, Wexler R, Simonetti OP, Jackson RD. Iron, inflammation and atherosclerosis risk in men vs. perimenopausal women. Atherosclerosis. 2015 Jul; 241(1):249-54.
-
Dwyer MG, Zivadinov R, Markovic-Plese S, Bergsland N, Heininen-Brown M, Carl E, Kennedy C, Weinstock-Guttman B, Hayward B, Dangond F. Associations between changes in ferritin levels and susceptibility-weighted imaging filtered phase in patients with relapsing-remitting multiple sclerosis over 24 weeks of therapy with subcutaneous interferon beta-1a three times weekly. J Neuroimmunol. 2015 Apr 15; 281:44-50.
-
Gladwin MT, Barst RJ, Gibbs JS, Hildesheim M, Sachdev V, Nouraie M, Hassell KL, Little JA, Schraufnagel DE, Krishnamurti L, Novelli E, Girgis RE, Morris CR, Berman Rosenzweig E, Badesch DB, Lanzkron S, Castro OL, Taylor JG, Goldsmith JC, Kato GJ, Gordeuk VR, Machado RF. Risk factors for death in 632 patients with sickle cell disease in the United States and United Kingdom. PLoS One. 2014; 9(7):e99489.